BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day
Go back to BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day| BARNES GROUP, Inc. (NYSE: B) | Delayed: 38.39 -1.75 (4.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.14 | 52 Week High | $44.27 | |||
| Open | $38.98 | 52 Week Low | $30.07 | |||
| Day High | $39.03 | P/E | 29.31 | |||
| Day Low | $38.33 | EPS | $1.31 | |||
| Volume | 5,334,776 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 22.26 +0.79 (3.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.47 | 52 Week High | $8.73 | |||
| Open | $20.90 | 52 Week Low | $2.86 | |||
| Day High | $22.45 | P/E | N/A | |||
| Day Low | $20.61 | EPS | $-3.82 | |||
| Volume | 218,754 | |||||
